Intraarterial urokinase produces significant attenuation of infarction volume in an embolic focal ischemia model

Experimental Neurology

Volumn 154, Issue 2, 1998, Pages 330-335

  Shuaib, Ashfaq ^a   Yang, Yi ^b   Siddiqui, Muzaffar M ^a   Kalra, Jay ^b  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

UROKINASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOT LYSIS; BRAIN EMBOLISM; BRAIN INFARCTION; BRAIN PROTECTION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; HISTOPATHOLOGY; INTRAARTERIAL DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032437457     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6925     Document Type: Article

References (26)

1. Mohr J. P. Some clinical aspects of acute stroke. Excellence in clinical stroke award lecture. Stroke. 28:1997;1835-1839.
2. New Engl. J. Med. 333:1995;1581-1587.
3. Grotta J. The current status of neuronal protective therapy: Why have all neuronal protective drugs worked in animals but none so far in stroke patients. Cerebrovasc. Dis. 4:1994;115-120.
4. Neuroprotective Agents and Cerebral Ischemia. 1997;Academic Press, New York. p. 47-68.
5. Longa E. Z., Weinstein P. R., Carlson S. E., Cummins R. Reversible middle cerebral artery occlusion witout craniectomy in rats. Stroke. 20:1989;84-91.
6. Kurz K. D., Main B. W., Sandusky G. E. Rat model of arterial thrombosis by ferric chloride. Thromb. Res. 60:1990;269-280.
7. Zhang Z., Zhanz R. L., Jiang Q., Raman S. B., Cantwell L., Chopp M. A new rat model of thrombotic focal cerebral ischemia. J. Cereb. Blood Flow Metab. 17:1997;123-135.
8. Benderson J. P., Pitts L. H., Tsuji M., Nishumura M. C., Davis R. L., Bartkowski H. M. Rat middle cerebral artery occlusion: evaluation of a model and development of neurological examination. Stroke. 17:1986;472-476.
9. Germano I., Pitts L. H., Meldrum B. S., Bartkowski H. M., Simon R. P. Kynurenate inhibition of cell excitation decreases stroke size and deficit. Ann. Neurol. 22:1987;730-734.
10. Osborne K. A., Shigeno T., Balarsky A. M. Quantitiative assessment of early brain damage in a rat model of focal cerebral ischemia. J. Neurol. Neurosurg. Psychiatr. 50:1987;402-410.
11. Duverger D., MacKenzie E. T. The quantification of cerebral infarction following focal ischemia in the rat: Influence of stain, arterial pressure, blood glucose concentration and age. J. Cereb. Blood Flow Metab. 8:1988;449-461.
12. Yang Yi, Shuaib Asfaq, Li Qiu. Quantification of infarct size on focal cerebral ischemia of rat model using a simple and economic method. J. Neurosci. Methods. 1998.
13. Lin T. N., He Y. Y., Wu K., Khan M., Hsu C. Y. Effects of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke. 24:1993;117-121.
14. Belayve L., Alonso O. F., Busto R., Zhao W., Ginsberg M. D. Middle cerebral artery occlusion in the rat by intraluminal suture. Stroke. 27:1996;1616-1623.
15. Obrenovich T. P. The ischemic penumbra: Twenty years on. Cerebr. Brain Metab. Rev. 7:1995;297-323.
16. Walhgren N. G. CLASS investigators. The chlormethiazole acute stroke study (CLASS): Results of a randomized controlled study of chlormethiazole versus placebo in 1360 patients. Cerebrovasc. Dis. 7:1997;19.
17. Yenari M. A., Crespigny A., Palmer J. T. Improved perfusion with rt-PA and Hirlog in a rabbit model of embolic stroke. J. Cereb. Blood Flow Metab. 17:1997;401-411.
18. Shuaib A., Ijaz S., Mazagri R., Senthilsevlvan A. CGS-19755 is neuroprotective during repetitive ischemia: This effect is significantly enhanced when combined with hypothermia. Neuroscience. 56:1993;915-920.
19. Lyden P., Lonzo L., Nunez S. Combination chemotherapy extends the therapeutic window to 60 minutes after stroke. J. Neurotrauma. 12:1995;223-230.
20. Watson B. D., Dietrich W. D., Busto R., Wachtel M., Ginsburg M. D. Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann. Neurol. 17:1985;504.
21. Zivin J. A., Fisher M., DeGirolami U., Hemenway C. C., Stashak J. A. Tissue plasmonogen activator reduces neurological damage after cerebral embolism. Science. 230:1985;1289-1292.
22. Zivin J. A., Lyden P. D., DeGirolami U. Tissue plasminogen activator: Reduction of neurological damage after experimental embolic stroke. Arch. Neurol. 45:1988;378-391.
23. Overgaard K., Sereghy T., Pefersen H., Boysen G. Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model. J. Cereb. Blood Flow Metab. 14:1994;422-427.
24. Benes V., Zabramski J. M., Boston M., Puca A., Spectzler R. F. Effect of intraarterial antifibinolytic therapy on autologous arterial emboli in the cerebral circulation in rabbits. Stroke. 21:1990;1594-1599.
25. Chehrezi B. B., Seibert J. A., Kissel P., Hein L., Brock J. M. Evaluation of recombinant tissue plasminogen activator in embolic stroke. Neurosurgery. 24:1989;355-360.
26. Carter L. P., Guthkelch A. N., Orozco J., Temeltas O. Influence of tPA and heparin on cerebral ischemia in a rabbit model. Stroke. 23:1992;883-888.